phloroglucinol has been researched along with Obesity, Morbid in 1 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, P | 1 |
| Fischer-Posovszky, P | 1 |
| Bischof, J | 1 |
| Radermacher, P | 1 |
| Wabitsch, M | 1 |
| Henne-Bruns, D | 1 |
| Wolf, AM | 1 |
| Hillenbrand, A | 1 |
| Knippschild, U | 1 |
1 other study available for phloroglucinol and Obesity, Morbid
| Article | Year |
|---|---|
Gene expression levels of Casein kinase 1 (CK1) isoforms are correlated to adiponectin levels in adipose tissue of morbid obese patients and site-specific phosphorylation mediated by CK1 influences multimerization of adiponectin.
Topics: Adipocytes; Adiponectin; Adolescent; Adult; Aged; Casein Kinase I; Female; Gene Expression Regulatio | 2015 |